English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2720]
News [7058]
Articles [271]
Editorials [8]
Conferences [215]
elearning [41]
Team identifies drug-like molecules that show early success in targeting breast cancer brain metastases
Team identifies drug-like molecules that show early success in targeting breast cancer brain metastases
Lab publishes papers pointing the way toward an exhaled-breath test for lung cancer
Lab publishes papers pointing the way toward an exhaled-breath test for lung cancer
Key driver for epithelial cancer development identified
Key driver for epithelial cancer development identified
Atomic force microscopy in the characterisation and clinical evaluation of neurological disorders
Atomic force microscopy in the characterisation and clinical evaluation of neurological disorders
The Biden Cancer Moonshot announces more than $100 million in new actions to decrease the burden of cancer in Africa
The Biden Cancer Moonshot announces more than $100 million in new actions to decrease the burden of cancer in...
Personalised simulations predict patient outcomes for blood cancer treatment in breakthrough study
Personalised simulations predict patient outcomes for blood cancer treatment in breakthrough study
A new proteogenomics analysis of high-grade gliomas offers hints on tumour evolution
A new proteogenomics analysis of high-grade gliomas offers hints on tumour evolution
Research validates TCM liver-breast cancer theory: fatty liver linked to deteriorating breast cancer
Research validates TCM liver-breast cancer theory: fatty liver linked to deteriorating breast cancer
Nerve damage from breast cancer treatment can be predicted
Nerve damage from breast cancer treatment can be predicted
Study finds 1 in 12 patients labeled as having ‘benign’ results actually had high-risk prostate cancer
Study finds 1 in 12 patients labeled as having ‘benign’ results actually had high-risk prostate cancer
<1...3132333435...706>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top